Effect [qlco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
tibolone [phsu, strd]
CARDIOVASCULAR [bdsy]
Metabolic [ftcn]
risk factors [qnco]
objectives [inpr]
hormone treatment [topp]
Menopause [phsf]
Affect [menp]
Lipid [lipd]
Carbohydrate Metabolism [moft]
Inflammation [patf]
MODIFY [ftcn]
risk factors [qnco]
Relevant [qlco]
Clinical [qlco]
Expression [topp]
Metabolic syndrome [dsyn]
Cardiovascular disease [dsyn]
tibolone [phsu, strd]
pharmacodynamic [biof]
properties [qlco]
Different [qlco]
Hormone preparation [mnob]
Compare [acty]
Effect [qlco]
combined treatment [topp]
Hormone [horm]
tibolone [phsu, strd]
Metabolic [ftcn]
Markers, Risk [qlco]
development [phsf]
Cardiovascular disease [dsyn]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
Assigned [ftcn]
mg day [qnco]
tibolone [phsu, strd]
Oral [spco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
cardiovascular risk factor [dsyn]
baseline [bodm]
months [tmco]
treatment [ftcn]
Result [ftcn]
Body Mass Index [diap]
Blood Pressure [orgf]
Unaffected [cnce]
hormone treatment [topp]
IR [geoa]
Decreased [qnco]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
P NOS [aapp, imft]
treatment [ftcn]
tibolone [phsu, strd]
increased activity [fndg]
Tissue-Type Plasminogen Activator [aapp, enzy, phsu]
IU/mL [qnco]
IU/mL [qnco]
P NOS [aapp, imft]
C-reactive protein [aapp, imft]
Decreased Activity [sosy]
Plasminogen activator inhibitor [aapp, bacs]
Triglycerides [bacs, lipd]
P NOS [aapp, imft]
Treatments [topp]
Decreased [qnco]
Total Cholesterol [lbpr]
Conclusions [idcn]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
tibolone [phsu, strd]
effects [qlco]
Metabolic [ftcn]
risk factors [qnco]
investigated [ftcn]
Effect [qlco]
tibolone [phsu, strd]
Fibrinolysis [phsf]
Triglycerides [bacs, lipd]
Suggest [idcn]
tibolone [phsu, strd]
Favorable [qlco]
Pharmacological [bmod]
Profile [lbpr]
risk factors [qnco]
Compared [acty]
Continuous [idcn]
Combined [qlco]
Conjugated estrogen + medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
